GSAC
|
Gelstat Corp
|
US
|
OTC
|
GSK
|
Glaxosmithkline Plc
|
UK
|
LSE
|
GSK
|
GlaxoSmithKline PLC
|
US
|
NYSE
|
HCM
|
Hutchison China MediTech Limited
|
US
|
NASDAQ
|
HCM
|
Hutchison China Meditech Limited
|
UK
|
LSE
|
HDRPF
|
Epsilon Healthcare Limited
|
US
|
US
|
HEXO
|
HEXO Corp.
|
US
|
NASDAQ
|
HIGH
|
CANTOURAGE GROUP SE O.N.
|
DE
|
F
|
HIK
|
Hikma Pharmaceuticals Plc
|
UK
|
LSE
|
HMPG
|
The Hempshire Group Corp.
|
CA
|
V
|
HOTH
|
Hoth Therapeutics, Inc.
|
US
|
NASDAQ
|
HPX
|
Hisamitsu Pharmaceutical Co. Inc
|
DE
|
F
|
HROW
|
Harrow Health, Inc.
|
US
|
NASDAQ
|
HRTIS
|
Herantis Pharma Oyj
|
FI
|
HE
|
HYPE3
|
Hypera S.A
|
BR
|
SA
|
HZNP
|
Horizon Pharma, Inc.
|
US
|
NASDAQ
|
IB3A
|
IONIC BRANDS CORP.
|
DE
|
F
|
IDT
|
IDT Australia Limited
|
AU
|
ASX
|
IGXT
|
Intelgenx Technologs
|
US
|
OTC
|
IMM
|
Immupharma Plc
|
UK
|
LSE
|